These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23508666)

  • 1. N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.
    Hosseinjani H; Moghaddas A; Khalili H
    Eur J Clin Pharmacol; 2013 Jul; 69(7):1375-90. PubMed ID: 23508666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.
    Anderson SM; Park ZH; Patel RV
    Ann Pharmacother; 2011 Jan; 45(1):101-7. PubMed ID: 21205947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
    Kelly AM; Dwamena B; Cronin P; Bernstein SJ; Carlos RC
    Ann Intern Med; 2008 Feb; 148(4):284-94. PubMed ID: 18283206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
    Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
    Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications.
    Dludla PV; Dias SC; Obonye N; Johnson R; Louw J; Nkambule BB
    Am J Cardiovasc Drugs; 2018 Aug; 18(4):283-298. PubMed ID: 29623672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
    Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
    JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
    Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
    Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast nephropathy.
    Curhan GC
    JAMA; 2003 Feb; 289(5):606-8. PubMed ID: 12578494
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
    Ashworth A; Webb ST
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):303-8. PubMed ID: 20570977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis.
    Kang X; Hu DY; Li CB; Ai ZS; Peng A
    Ren Fail; 2015 Nov; 37(10):297-303. PubMed ID: 26458505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
    Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
    Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
    Briguori C; Quintavalle C; De Micco F; Condorelli G
    Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach for the prevention of contrast nephropathy.
    Colbay M; Yuksel S; Uslan I; Acarturk G; Karaman O; Bas O; Mollaoglu H; Yagmurca M; Ozen OA
    Exp Toxicol Pathol; 2010 Jan; 62(1):81-9. PubMed ID: 19327972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of N-acetylcysteine in optimization of specific pharmacological therapies].
    Hołyńska-Iwan I; Wróblewski M; Olszewska-Słonina D; Tyrakowski T
    Pol Merkur Lekarski; 2017 Sep; 43(255):140-144. PubMed ID: 28987048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
    Feng Y; Huang X; Li L; Chen Z
    Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine pretreatment ameliorates mercuric chloride-induced oxidative renal damage in rats.
    Ekor M; Adesanoye OA; Farombi EO
    Afr J Med Med Sci; 2010 Dec; 39 Suppl():153-60. PubMed ID: 22416658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.